Co-Occurring Psychiatric Symptoms in Opioid-Dependent Women: The Prevalence of Antenatal and Postnatal Depression

Abstract

Routine screening for perinatal and postpartum depression is indicated for women diagnosed with substance abuse disorders.

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine

“…132 Many women also live in substandard housing, are unemployed, and have a history of sexual abuse, intimate partner violence, or sexual assault. 133,134 Collaborative care offers the opportunity to address these and other co-occurring health issues during pregnancy. Interaction with different agencies and health-care providers who participate in a collaborative care coalition exposes these women to the possibility of continued care for themselves and their families throughout their lives.…”

A New Parental Mentalization Focused Ultrasound Intervention for Substance Using Pregnant Women. Effect on Self-reported Prenatal Mental Health, Attachment and Mentalization in a Randomized and Controlled Trial

“…On average, the participants self-reported surprisingly low levels of prenatal depressive and anxiety symptoms considering their high-risk situation and the accumulation of severe risks for prenatal mental disorders (Fellenzer and Cibula 2014;Lancaster et al 2010). The prevalence of prenatal depression was smaller at both time points compared to previous studies with similar samples (Holbrook and Kaltenbach 2012;Ordean et al 2013). Compared to results from a population-based birth cohort in Finland (Tolvanen et al 2013), the participants in the current study only reported slightly higher levels of prenatal anxiety and depressive symptoms, and mostly in the earlier phase of pregnancy.…”

“…Indeed, substance use while pregnant has been associated with a high level of prenatal stress (Woods et al 2010) and the prevalence of maternal perinatal mental disorders (Holbrook and Kaltenbach 2012;Strengell et al 2014). The prevalence of prenatal depression has been reported to be around 40-50% among substance using women (Holbrook and Kaltenbach 2012;Ordean et al 2013;Pajulo et al 2011a) which is high compared to an approximate prevalence of 10% in a normal population of pregnant women (Gavin et al 2005). Unfortunately, the comorbidity of substance use disorders and prenatal stress adversely affects maternal and fetal health through multiple divergent pathways.…”

Association of Mood and Anxiety Disorders and Opioid Prescription Patterns Among Postpartum Women

“…These findings are of significant public health importance, as previous research has shown individuals with mental health conditions are at an increased risk of developing substance use conditions 27,31,32 . Perinatal depression is one of the most common medical conditions related to pregnancy and childbirth in the United States 4‐6 .…”